Pliant Therapeutics Inc.
09/27/2024 | Press release | Distributed by Public on 09/27/2024 14:12
Amendments to Bylaws Form 8 K
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On September 24, 2024, the Board of Directors of Pliant Therapeutics, Inc. (the "Company") approved the amendment and restatement of the Bylaws of the Company (as so amended and restated, the "Third Amended and Restated Bylaws"). The Third Amended and Restated Bylaws are effective as of September 24, 2024.
The amendments effected by the Third Amended and Restated Bylaws, among other things: (i) align the Company's bylaws with developments in Delaware law and jurisprudence; (ii) revise the procedural and disclosure requirements applicable to stockholders' director nominations and proposals for other business; and (iii) include a provision regarding severability. The Third Amended and Restated Bylaws also implement certain other ministerial and conforming changes.
The foregoing description does not purport to be complete and is qualified in its entirety by the complete text of the Third Amended and Restated Bylaws, a copy of which is filed herewith as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.